Open Access Short Communication Article ID: JCMC-1-110

    Acute Effect of Aliskiren on Smoking-Induced Endothelial Dysfunction in Smoker

    Haruhito Adam Uchida*, Hatsuzo Uchida and Jun Wada

    Background: We aimed to examine the acute effect of aliskiren on smoking-induced endothelial dysfunction in smoker.

    Methods: Nineteen male smokers were enrolled. After all participants smoked a cigarette, their endothelial function was assessed with brachial artery flow mediated dilation (FMD). An hour after the administration of aliskiren, they smoked again, their FMD was assessed again. A month later, all measurements were performed again without the administration of aliskiren as a control. Blood pressure, plasma renin activity, and serum interleukin-6 concentration were also examined at the same time of FMD measurement.

    Results: A cigarette smoking led to an acute endothelial dysfunction (6.5 ± 1.7% to 3.4 ± 1.0 %, P = 0.02). Aliskiren administration significantly suppressed blood pressure and plasma renin activity, furthermore, improved FMD (6.7 ± 0.5% to 8.1 ± 0.8 %, P = 0.03). Aliskiren significantly reduced serum interleukin-6 concentration, but not in control.

    Conclusion: Aliskiren has a beneficial effect on smoking-induced acute endothelial dysfunction.

    Keywords: Endothelial function; Smoking; Aliskiren; Interleukin-6

    Published on: Oct 27, 2014 Pages: 38-41

    Full Text PDF Full Text HTML DOI: 10.17352/2455-2976.000010
    CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat


    Case Reports

    Pinterest on JCMC

    Help ? Google Reviews 11